Tranexamic Acid Injection, Solution
Product Images NDC 25021-415

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 25021-415). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Tra1j 0000 01)

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Tra1j 0000 02)

Package Label – Principal Display Panel – Vial Label (Tra1j 0000 02)
This is a description for Tranexamic Acid Injection, USP. It is provided in a 10mL single-dose vial, with each vial containing 1g of tranexamic acid. The medication is intended for intravenous use only and should be stored between 15° to 30°C. The product is sterile, nonpyrogenic, and preservative-free. The dosage information can be found in the package insert. Unused portions should be discarded, and the product should be stored at 20° to 25°C.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.